Clinical Considerations of Isavuconazole Administration in High-Risk Hematological Patients: A Single-Center 5-Year Experience

BACKGROUND: There are limited real-life data on isavuconazole prophylaxis and treatment of invasive mold infections (IMI) in hematological patients and allogeneic hematopoietic cell transplant (HCT) recipients. OBJECTIVES: Primary objective was to describe the indications of real-life isavuconazole...

Descripción completa

Detalles Bibliográficos
Autores principales: Kronig, Ilona, Masouridi-Levrat, Stavroula, Chalandon, Yves, Glampedakis, Emmanouil, Vernaz, Nathalie, Van Delden, Christian, Neofytos, Dionysios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602163/
https://www.ncbi.nlm.nih.gov/pubmed/34432216
http://dx.doi.org/10.1007/s11046-021-00583-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602163/
https://www.ncbi.nlm.nih.gov/pubmed/34432216
http://dx.doi.org/10.1007/s11046-021-00583-9

Ejemplares similares